vTv Therapeutics (VTVT) Long-Term Investments (2017 - 2023)

vTv Therapeutics has disclosed Long-Term Investments across 7 years of filings, most recently posting $4.4 million for Q3 2023.

• In Q3 2023, Long-Term Investments fell 28.96% year-over-year to $4.4 million; the TTM figure through Sep 2023 stood at $4.4 million (down 28.96% YoY), while the FY2022 annual figure was $5.6 million, down 39.08% from the prior year.
• Long-Term Investments came in at $4.4 million for Q3 2023 at vTv Therapeutics, down from $8.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $9.6 million in Q2 2021 to a low of $2.5 million in Q1 2019.
• Average Long-Term Investments over 5 years is $5.4 million, with a median of $5.8 million recorded in 2022.
• Year-over-year, Long-Term Investments soared 287.98% in 2021 and slumped 40.01% in 2022.
• Over 5 years, Long-Term Investments stood at $2.5 million in 2019, then jumped by 171.17% to $6.7 million in 2020, then jumped by 36.4% to $9.2 million in 2021, then slumped by 39.08% to $5.6 million in 2022, then declined by 21.49% to $4.4 million in 2023.
• Per Business Quant data, the three most recent Long-Term Investments figures were $4.4 million in Q3 2023, $8.0 million in Q2 2023, and $7.7 million in Q1 2023.